Friday, August 13, 2021 11:56:54 AM
To me it was so obvious to concentrate on LaCoste to keep expenses down, get the production cycle established from importation of Larvae to weekly shipments to local stores..thereby proving the method and consumer acceptance and profitablity. Then license the patent and production model and monitor and manage facilities around the world right there from Dallas.
Plus I see tons of shrimp selling in Costco..cooked with tails on selling to customers for what SHMP will need to sell to Costco to even make money.
As great a deal as Iowa was...and I initially thought it was smart... I now see it as too much reach using too much borrowed money.
They really needed to use crowdfunding to sell shares at much higher prices and no shitty loan terms.
Good luck to all.
Recent SHMP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:31:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:30:31 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:56:11 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 10:01:21 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/08/2023 03:52:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 08:31:49 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/15/2023 04:15:19 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 09:20:31 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/11/2023 08:52:47 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/07/2023 09:04:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2023 09:20:28 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM